ENTERAHEALTH, INC. – Trademark Portfolio

Entity Type: 03

ENTERAHEALTH, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ENTERAGAM, IMMUNOLIN, and ENTERA HEALTH. The owner is based in ANKENY, IA.

2425 SE OAK TREE COURT

ANKENY, IA 50021

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ENTERAHEALTH, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does ENTERAHEALTH, INC. have?

ENTERAHEALTH, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 5 registered, 7 abandoned, 1 cancelled.

What trademark classes does ENTERAHEALTH, INC. file in?

ENTERAHEALTH, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ENTERAHEALTH, INC.'s most well-known trademarks?

ENTERAHEALTH, INC.'s registered trademark portfolio includes well-known marks such as ENTERAGAM, IMMUNOLIN, and ENTERA HEALTH. These are among 5 currently registered trademarks in the portfolio.

What is ENTERAHEALTH, INC.'s trademark registration success rate?

ENTERAHEALTH, INC. has a 38% trademark registration rate, with 5 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.